Oncology

Latest News

Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

By Mary Caffrey

April 17th 2025

These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.

Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

By Kyle Munz

April 14th 2025

Businessman shows medical network wooden block for health, medicine, insurance, healthcare, care, concept. Medical technology services to solve public - ภัทรชัย รัตนชัยวงค์ - stock.adobe.com.jpeg

NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

By Giuliana Grossi

April 9th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

By Galen Shearn-Nance, BS
Rishi R. Sachdev, BS

April 4th 2025

Woman with keloid on shoulder | Image credit: weerajata – stock.adobe.com

Deep Learning Tool Differentiates Keloids From Malignant Lesions Without Dermoscopy

By Hayden E. Klein

April 2nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

April 21st 2017

5 Ways the COA Meeting Will Help Oncology Practices Succeed

Surabhi Dangi-Garimella, PhD

At this year’s meeting, themed Fueling the Cancer Moonshot, attendees will gain a better understanding of strategies for success within the community oncology realm.

April 21st 2017

This Week in Managed Care: April 21, 2017

This week, the top managed care stories included a new rule from CMS to end abuse on the Affordable Care Act insurance exchanges; a study that indicates type 2 diabetes may possibly be reversed; and CareMore unveils a new care model that takes place in the dentist's chair.

April 21st 2017

Dr Matthew Gubens: Multidisciplinary Approach Can Help Oncologists Tackle Immunotherapy Toxicities

When employing immunotherapies, oncologists must be vigilant in spotting any adverse events and calling in their colleagues, like dermatologists or pulmonologists, to help manage these toxicities, according to Matthew Gubens, MD, MS, assistant clinical professor of thoracic oncology at the University of California, San Francisco.

April 20th 2017

FDA Wants Researchers to Rethink Patient Eligibility Criteria

Surabhi Dangi-Garimella, PhD

Although the purpose of eligibility criteria is to protect patients from unnecessary harm, define the study population, and allow researchers to collect safety and efficacy data for a specific population, unnecessary restriction may not capture the heterogeneity of real-world patients.

April 20th 2017

Paxman Scalp Cooling System Is FDA Approved for Chemotherapy-Associated Alopecia

Surabhi Dangi-Garimella, PhD

The approval of the Paxman Scalp Cooling System follows a randomized clinical trial, whose results were published in JAMA following an interim analysis.

April 20th 2017

Transparency and Collaboration Key to the Success of Value-Based Payment Models

Joseph Alvarnas, MD

As the task of describing value delivery in cancer care seems to grow in complexity the closer that we examine it, this is essential in order to both rationally control the growth of healthcare costs and ensure that we do not undermine patient care.

April 19th 2017

Why Oncologists Need Technology to Succeed in Alternative Payment Models

Brenton Fargnoli, MD Ryan Holleran

The emergence of alternative payment models, as exemplified by the Oncology Care Model, is requiring oncologists to develop new solutions to meet the requirements of these programs. Technology available at the point of care offers an efficient solution to many of the most labor-intensive processes.

April 19th 2017

ASCO Policy Statement Questions Payer Utilization Management Strategies

Surabhi Dangi-Garimella, PhD

The American Society of Clinical Oncology (ASCO) has raised concerns that utilization management strategies, especially for high-cost prescription drugs, could reduce patient access.

April 19th 2017

Cancer-Based Workplace Discrimination Persists Despite Disability Law, Study Finds

Christina Mattina

Amendments to the Americans with Disabilities Act in 2009 have not eliminated instances of workplace discrimination against employees with cancer, according to a recently published study.

April 18th 2017

PCORI-Funded Study Advises Patient Preference When Treating Prostate Cancer

Surabhi Dangi-Garimella, PhD

JAMA study highlights need for considering patient preferences when choosing between treatment options for prostate cancer.

April 18th 2017

Value-Based Payment Models in Oncology: Will They Help or Hinder Patient Access to New Treatments?

Sonal Shah, PharmD Greg Reh

The Deloitte Center for Health Solutions recently interviewed individuals from health plans, providers, and clinical pathway developers that are participating, supporting, or evaluating oncology payment models to understand what approaches are perceived to be working, the early results, and the potential impact on innovation.

April 18th 2017

Atezolizumab Now a First-Line Option for Cisplatin-Ineligible Patients With Advanced Bladder Cancer

Surabhi Dangi-Garimella, PhD

The approval comes following phase 2 results of 119 patients who participated in the IMvigor210 study.

April 18th 2017

Dr Marianne Fazen on the Value for Employers in the Oncology Care Model

Oncology care management helps coordinate the clinical aspects of cancer treatment, but it would also be helpful to have a benefits manager to help guide patients through their many options, said Marianne Fazen, PhD, president and CEO of the Texas Business Group on Health.

April 17th 2017

An Oncologist's Perspective: Preparation for New Payment Models in Cancer Care

Sachin M. Apte, MD, MS, MBA

A dive into the Quality Payment Program and other healthcare reform models introduced in cancer care that healthcare providers are adjusting to as we move toward value-based care.

April 17th 2017

How to Create Successful Alternative Payment Models in Oncology

Harold D. Miller

By identifying ways to improve cancer care and then designing alternative payment models (APMs) to overcome current payment barriers, APMs can enable oncology practices to deliver better care to patients and save money for payers in a way that is financially sustainable for the practices.

April 17th 2017

Four in Five Mentally Ill Women on California Medicaid Not Screened for Cervical Cancer

Christina Mattina

A new study has found some concerning gaps in cervical cancer screening among a vulnerable population: women with severe mental illness enrolled in a state Medicaid program.

April 17th 2017

Study Questions Validity of Genetic Variant Classification in Public Databases

Surabhi Dangi-Garimella, PhD

A study published in The Oncologist concluded that discrepant variant classification in public databases can introduce uncertainty and diminish patient care.

April 15th 2017

Podcast: This Week in Managed Care - Guidelines Controversy, and Other News

Every week, The American Journal of Managed CareÂ® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

April 14th 2017

This Week in Managed Care: April 14, 2017

This week, the top managed care stories include an update for prostate cancer screening guidelines; the consequences of conflicting breast cancer guidelines; and Florida seeks work requirements for Medicaid.

April 13th 2017

Are Surgeons Adept at Handling BRCA1/2 Mutations of Uncertain Significance?

Surabhi Dangi-Garimella, PhD

Study identifies need for surgeons to maximize benefits of genetic testing for surgical decisions in breast cancer.

April 12th 2017

Oral Chemotherapy Adherence Affected by Patient Satisfaction With Oncologist and Treatment

Christina Mattina

A new study has explored factors that impact patient adherence to oral chemotherapy regimens and found that improved satisfaction with their treatment and clinician was most strongly linked to better adherence.

April 11th 2017

Alternative to Colonoscopy Is Now in Medicare's Star Ratings

Mary Caffrey

Adding a test that evaluates stool samples for DNA and protein biomarkers to the list of tools providers can use to boost quality ratings is seen as an additional boost for Cologuard.

April 11th 2017

Conflicting Breast Cancer Screening Guidelines Lead to Varying Physician Recommendations

Christina Mattina

A new study published in JAMA Internal Medicine has found that the extent to which clinicians follow breast cancer screening guidelines for patients of different ages varies by their specialty and by which set of recommendations they trust most.

April 11th 2017

Fetal Exposure to Cigarette Smoke Causes Genetic Changes, Raises Risk of Pediatric ALL

Surabhi Dangi-Garimella, PhD

Exposure to tobacco smoke as a fetus or during early childhood can cause genetic changes that can increase a child’s risk of developing acute lymphoblastic leukemia (ALL).

April 11th 2017

What We're Reading: SCOTUS to Hear Biosimilar Case; Prostate Cancer Screening; Fitness Trackers

AJMC Staff

April 11th 2017

Dr David L. Porter Discusses Side Effects of CAR-T Cell Therapy

CAR-T cell treatment can have a number of side effects, with the most serious being cytokine release syndrome, according to David L. Porter, MD, of the University of Pennsylvania Health System. However, there are some promising therapies like interleukin-6 blockers that can reverse this reaction.

April 10th 2017

Hospice Use Less Common for Minority Women With Ovarian Cancer

Christina Mattina

A new study finds that women with ovarian cancer who were black or Hispanic tended to undergo more aggressive treatment and were less likely to receive hospice services at the end of life.

April 10th 2017

Do We Need Biomarkers to Predict Tumor Hyper-Progression Following Immunotherapy?

Surabhi Dangi-Garimella, PhD

A new study published in Clinical Cancer Research provides evidence that researchers can use biomarkers to identify patients whose tumors will grow at a faster rate following immunotherapy treatment.

April 9th 2017

Samantha Watson on the Importance of Patient-Provider Discussions About Cancer Costs

Providers have a responsibility to discuss the costs of cancer care with their patients earlier on, so the patients aren’t blindsided by enormous bills, said Samantha Watson, founder and CEO of The Samfund. These conversations would help patients prepare for the financial realities associated with cancer.

April 9th 2017

Racial Disparities in Health-Related Quality of Life for Patients With Colorectal Cancer

AJMC Staff

Hispanics and blacks with colorectal cancer report a higher burden of poor health-related quality of life (HR-QoL) compared with white patients, according to study results presented at the annual meeting of the American Association for Cancer Research.

...

75 76 77 78 79 80 81 82 83

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions